2,4-dihydroxymethylcinnamate,
2,5-dihydroxycinnamic acid methyl ester,
methyl 2,5-dihydroxycinnamate,
Methyl 2,5-dihydroxycinnamate,
63177-57-1,
erbstatin analog,
methyl 3-(2,5-dihydroxyphenyl)acrylate,
2,5-Dihydroxycinnamic acid methyl ester,
2,4-Dihydroxymethylcinnamate,
2,5-Dihydroxymethylcinnamate,
CHEMBL17329,
CHEBI:84089,
Methyl 3-(2,5-dihydroxyphenyl)-2-propenoate,
MFCD00132932,
2-Propenoic acid, 3-(2,5-dihydroxyphenyl)-, methyl ester,
(E)-methyl 3-(2,5-dihydroxyphenyl)acrylate,
methyl (E)-3-(2,5-dihydroxyphenyl)acrylate,
methyl (E)-3-(2,5-dihydroxyphenyl)prop-2-enoate,
methyl (2E)-3-(2,5-dihydroxyphenyl)prop-2-enoate,
methyl 3-(2,5-dihydroxyphenyl)prop-2-enoate,
methyl grevillate,
AC1NS4DB,
BiomolKI_000061,
BiomolKI2_000067,
2-Propenoic acid,3-(2,5-dihydroxyphenyl)-, methyl ester,
BMK1-G1,
Methyl 2,5-dihydoxycinnamate,
methyl-2,5-dihydroxycinnamate,
SCHEMBL343784,
CHEBI:93543,
BQCNSTFWSKOWMA-GORDUTHDSA-N,
HMS3675G10,
ZINC2504592,
1850AH,
BDBM50025624,
FCH839657,
HSCI1_000370,
AKOS006271583,
CCG-100665,
FCH3703560,
VZ22771,
SMP2_000107,
NCGC00024661-02,
AK162178,
CC-07788,
methyl 3-(2',5'dihydroxyphenyl)acrylate,
AX8000057,
LS-176296,
B6358,
ST24047762,
2,5-Dihydroxybenzeneacrylic acid methyl ester,
2,5-Dihydroxymethylcinnamate; Erbstatin Analog,
K00021,
Methyl (2E)-3-(2,5-dihydroxyphenyl)acrylate,
A834253,
SR-01000597715,
SR-01000597715-1,
BRD-K35573744-001-02-7,
BRD-K88741031-001-01-0,
methyl (E)-3-[2,5-bis(oxidanyl)phenyl]prop-2-enoate,
(E)-3-(2,5-dihydroxyphenyl)-2-propenoic acid methyl ester,
2,5-Dihydroxycinnamic acid methyl ester, >=95%, crystalline,
C10H10O4,
METHYL2,5-DIHYDROXYCINNAMATE,
C10-H10-O4,
CID5353609,
C067472,
2-Propenoic acid, 3-(2,5-dihydroxyphenyl)-, methyl ester, (2E)-,
123064-80-2,